NYSE : ACH
-$1.4 (-50.0%)
| Source | Headline |
|---|---|
|
Accendra Health, Inc. (ACH) Q2 2026 Earnings Call Transcript
Accendra Health, Inc. (ACH) Q2 2026 Earnings Call Transcript seekingalpha.com - 2026-08-10 13:08:28 |
|
Accendra Health Announces Adoption of Tax Asset Preservation Plan To Protect Long Term Shareholder Value
RICHMOND, Va.--(BUSINESS WIRE)--Accendra Health, Inc. (NYSE: ACH) (the Company) announced today that its Board of Directors adopted a Section 382 Rights Agreement (the “Tax Asset Preservation Plan”) designed to protect long-term shareholder value by facilitating the Company's ability to preserve its net operating loss carryforwards (“NOLs”) and certain other tax attributes. A company generally experiences an ownership change if the percentage of the value of its stock owned by certain “5-percen. businesswire.com - 2026-08-10 06:50:00 |
|
Accendra Health Reports Second Quarter 2026 Financial Results
RICHMOND, Va.--(BUSINESS WIRE)--Accendra Health, Inc. (NYSE: ACH) (the Company) today reported financial results for the second quarter ended June 30, 2026. Unless otherwise noted, the results herein reflect the Company's continuing operations, which represent what was previously the Patient Direct segment and certain functional operations. “Throughout the second quarter, we moved farther along toward the complete separation from Owens & Minor while also putting a large commercial payor exi. businesswire.com - 2026-08-10 06:45:00 |
|
Accendra Health's Ed Pesicka Announces Intent to Retire; Board of Directors Has Begun Successor Search
RICHMOND, Va.--(BUSINESS WIRE)--Accendra Health, Inc. (NYSE: ACH) (the Company) today announced that President and Chief Executive Officer Edward A. Pesicka has informed the Board of Directors of his plan to retire by the end of 2026, after more than seven years with the Company. Mr. Pesicka will also retire from the Company's Board of Directors before the end of the year. The Board of Directors maintains a long-standing, robust succession planning process established to address officer success. businesswire.com - 2026-08-10 06:30:00 |
|
Credova Expands Guidefitter Relationship, Bringing ACH Payments to Marketplace Checkout and the Guidefitter Wallet
BOZEMAN, Mont.--(BUSINESS WIRE)--PSQ Holdings, Inc. (NYSE: PSQH) today announced that Guidefitter, the outdoor tech platform powering the industry's most comprehensive verified pro network, has selected Credova and PSQ Payments to power ACH payments across its marketplace checkout and the Guidefitter Wallet, the platform's digital wallet for its members. The transition comes just days after Guidefitter's existing ACH provider elected to stop processing transactions and confirms PSQ Payments' ab. businesswire.com - 2026-07-31 08:30:00 |
|
Accendra Health Announces Second Quarter 2026 Earnings Release Date and Conference Call
Accendra Health, Inc. (NYSE: ACH) (the âCompanyâ) plans to release financial results for the second quarter of 2026 on Monday, August 10, 2026, before tradi gurufocus.com - 2026-07-27 10:00:00 |
|
Accendra Health Announces Second Quarter 2026 Earnings Release Date and Conference Call
RICHMOND, Va.--(BUSINESS WIRE)--Accendra Health, Inc. (NYSE: ACH) (the “Company”) plans to release financial results for the second quarter of 2026 on Monday, August 10, 2026, before trading begins on the New York Stock Exchange. The Company will host a conference call for investors and analysts at 8:00 a.m. EDT on the same day. Participants may access the call via the toll-free dial-in number at 1-888-300-2035, or the toll dial-in number at 1-646-517-7437. The conference ID access code is 1058. businesswire.com - 2026-07-27 09:15:00 |
|
Is the Options Market Predicting a Spike in Accendra Health Stock?
Investors need to pay close attention to ACH stock based on the movements in the options market lately. zacks.com - 2026-07-02 10:06:30 |
|
Accendra Health Announces Expiration and Final Results of Offers and Consent Solicitations
Accendra Health, Inc. (NYSE: ACH) (the âCompanyâ) today announced the expiration and final results of the previously announced offers to exchange (the âE gurufocus.com - 2026-06-23 22:00:00 |
|
Accendra Health Announces Expiration and Final Results of Offers and Consent Solicitations
RICHMOND, Va.--(BUSINESS WIRE)--Accendra Health, Inc. (NYSE: ACH) (the “Company”) today announced the expiration and final results of the previously announced offers to exchange (the “Exchange Offers”) any and all of the Company's outstanding 4.500% Senior Notes due 2029 (the “2029 Notes”) and 6.625% Senior Notes due 2030 (the “2030 Notes” and, together with the 2029 Notes, the “Existing Notes”). As of 5:00 P.M., New York City time, on June 23, 2026 (the “Expiration Time”), the Company received. businesswire.com - 2026-06-23 21:15:00 |
|
Accendra Health Announces Early Results of Offers and Consent Solicitations
Accendra Health, Inc. (NYSE: ACH) (the âCompanyâ) today announced the early results of the previously announced offers to exchange (the âExchange Offersâ gurufocus.com - 2026-06-10 07:00:00 |
|
Accendra Health Announces Early Results of Offers and Consent Solicitations
RICHMOND, Va.--(BUSINESS WIRE)--Accendra Health, Inc. (NYSE: ACH) (the “Company”) today announced the early results of the previously announced offers to exchange (the “Exchange Offers”) any and all of the Company's outstanding 4.500% Senior Notes due 2029 (the “2029 Notes”) and 6.625% Senior Notes due 2030 (the “2030 Notes” and, together with the 2029 Notes, the “Existing Notes”). Eligible Holders of 2029 Notes that participate in the New Money Notes Issuance (as defined below) will be able to. businesswire.com - 2026-06-10 06:30:00 |
|
Accendra Health Announces Offers and Consent Solicitations
RICHMOND, Va.--(BUSINESS WIRE)--Accendra Health, Inc. (NYSE: ACH) (the “Company”) today announced that it has commenced an offer to exchange (the “Exchange Offers”) any and all of the Company's outstanding 4.500% Senior Notes due 2029 (the “2029 Notes”) and 6.625% Senior Notes due 2030 (the “2030 Notes” and, together with the 2029 Notes, the “Existing Notes”). Eligible Holders of 2029 Notes that participate in the New Money Notes Issuance (as defined below) will be able to exchange such 2029 No. businesswire.com - 2026-05-22 16:01:00 |
|
Accendra Health, Inc. (ACH) Shareholder/Analyst Call Prepared Remarks Transcript
Accendra Health, Inc. (ACH) Shareholder/Analyst Call Prepared Remarks Transcript seekingalpha.com - 2026-05-14 10:46:27 |
|
Accendra Health Makes Progress Addressing Its Debt Load
Accendra Health, Inc. is undergoing a multiyear turnaround, focusing on at-home medicine after divesting its hospital supply unit and cleaning up its balance sheet. ACH's recent refinancing extends maturities, reduces gross debt by ~$100 million, and provides a liquidity runway, enhancing the probability of successful long-term deleveraging. Management reaffirmed full-year guidance, but ongoing margin pressure and slow volume growth mean EBITDA will likely be at the lower end of the outlook. seekingalpha.com - 2026-05-11 14:33:49 |
|
Accendra Health, Inc. (ACH) Q1 2026 Earnings Call Transcript
Accendra Health, Inc. (ACH) Q1 2026 Earnings Call Transcript seekingalpha.com - 2026-05-11 13:30:41 |
|
Accendra Health Reports First Quarter 2026 Financial Results and Announces Comprehensive Balance Sheet Optimization Transaction
RICHMOND, Va.--(BUSINESS WIRE)--Accendra Health, Inc. (NYSE: ACH) today reported financial results for the first quarter ended March 31, 2026, and announced a more than $1.5 billion comprehensive balance sheet optimization transaction with commitments from existing creditors that will strengthen the balance sheet, significantly extend maturities and reduce total leverage. Unless otherwise noted, the results herein reflect the Company's continuing operations, which represent what was previously. businesswire.com - 2026-05-11 06:30:00 |